Loading...
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment
Imatinib mesylate treatment markedly reduces the burden of leukemia cells in chronic myelogenous leukemia (CML) patients. However, patients remain at risk for relapse on discontinuing treatment. We have previously shown that residual BCR-ABL(+) progenitors can be detected in CML patients within the...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3217358/ https://ncbi.nlm.nih.gov/pubmed/21931114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-12-327437 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|